Resultsbee.com

200 Medical Plaza Driveway Suite 22-442 MDCC,Los Angeles,CA

James D. Cherry, MD, MSc is a Distinguished Research Professor at the David Geffen School of Medicine at UCLA and UCLA Mattel Children's Hospital, Division of Infectious Diseases. Dr. Chery received his MD degree from the University of Vermont in 1957 and his MSc degree in Epidemiology from the London School of Hygiene and Tropical Medicine in 1983. He received his pediatric residency training at Boston City Hospital and Kings County Hospital and his infectious diseases fellowship training at the Thorndike Memorial Laboratory, Harvard Medical Service at Boston City Hospital. Following his infectious diseases fellowship training, Dr. Cherry established one of the first formal pediatric infectious disease fellowship programs in the world in 1963 at the University of Wisconsin. In 1973 Dr. Cherry started the first pediatric infectious training program at UCLA. During his 47 years tenure at UCLA, numerous trainees have gone on to be leaders in pediatric infectious diseases in the United States and other countries throughout the world. In 1969-70, Dr. Cherry was a visiting worker at the Medical Research Council, Common Cold Research Unit and Clinical Research Centre, Salisbury, England. From 1989 to 1996, Dr. Cherry and associates carried out an extensive pertussis vaccine efficiency trail in Erlanger, Germany. In 2000-2001, he was a visiting scholar in the Department of Clinical Veterinary Medicine, University of Cambridge, England. In addition, Dr. Cherry was the director of a vaccine reaction study in Denmark at a participant in two USAID nutrition/immunology projects in Kenya. Throughout his career, Dr. Cherry has received numerous national and international awards. Some of these include: The John and Mary B. Markle Scholar in Academic Medicine; Distinguished Physician Award of the Pediatric Infectious Diseases Society; The Stanley A. Plotkin Lectureship in Vaccinology of the Pediatric Infectious Diseases Society; The European Society for Pediatric Infectious Diseases Bill Marshall Award; The American Academy of Pediatrics Section on Infectious Diseases Award for Lifetime Contribution to Infectious Diseases Education; and The UCLA, Edward A. Dickson Emeritus Professorship Award. Dr. Cherry has published 323 research papers, 109 editorials and commentaries and 303 book chapters. He is the senior editor of Feigin and Cherry's Textbook of Pediatric Infectious Disease, which is now in its 8th edition. Dr. Cherry's laboratory experience involved virology, mycoplasmology, serology, and molecular microbiology. His main research over the last 57 years has been related to vaccines and vaccine preventable diseases (measles, rubella, influenza, smallpox, and pertussis). A major interest since 1976 relates to pertussis epidemiology and pertussis vaccines. Over the last 10 years, he and colleagues at the California Department of Public Health and California pediatric infectious diseases physicians have been studying severe pertussis in young infants. Another area of interest has been measles and measles vaccines. He and colleagues first described secondary measles vaccine failure in 1972 in Saint Louis and more recently in California. He presently is involved in measles related studies in the Democratic Republic of the Congo and in Switzerland. Finally, he has been involved in Zika virus studies in Brazil.

(131) 082 - 5522

2121 Santa Monica Blvd Garden Level,Santa Monica,CA

Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

(131) 058 - 2710

1245 Wilshire Blvd Suite 303,Los Angeles,CA

Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

(180) 020 - 3551

240 South Jackson Street Suite 109,Glendale,CA

Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

(180) 020 - 3551

200 Medical Plaza Driveway Suite 265,Los Angeles,CA

Yvonne J. Bryson, MD is a Professor of Pediatrics and Chief of Pediatric Infectious Diseases at the David Geffen School of Medicine at UCLA and UCLA Mattel Children’s Hospital and is the Director of the Los Angeles Brazil AIDS Consortium. She is a world-renown leader, researcher, virologist and clinician in the field of HIV pathogenesis, prevention and treatment of maternal-fetal and pediatric HIV-1, and is an active member of the Pediatric AIDS Clinical Trial Group. She is currently the Chair of the NIH Network IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) PMTCT Committee (Prevention of Mother-to-Child Transmission of HIV). An invited member on the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus, Dr. Bryson was influential in the development of CDC and Public Health guidelines for the diagnosis and treatment of HIV-infected pregnant women and has been involved in the planning and execution of national cooperative studies of maternal-fetal HIV transmission. She has made significant contributions to the development of some of the original studies of the use of Zidovudine for the prevention of perinatal HIV, studies of maternal risk factors for vertical transmission of HIV, as well as advances in the early diagnosis of HIV in newborns. Dr. Bryson has significant experience in leading large multicenter clinical trials and networks and developing clinical sites and laboratories. She is recognized as a national and international expert and leader in the field of HIV and perinatal transmission. She has made important and original scientific contributions to the field and served on many advisory committees and NIH Study Sections, and has been consistently funded by the National Institutes of Health, including numerous RO1 grants. Dr. Bryson has mentored numerous postdoctoral fellows and young faculty for successful careers in academic medicine. She was one of the original members of the Elizabeth Glaser Pediatric AIDS Foundation heath advisory board and helped start the foundation with Elizabeth, Dr. Richard Stiehm, and two co-founders. She has made a strong commitment to international studies and to her collaborators in Brazil to help them develop the necessary infrastructure to design, conduct, and implement new approaches to prevent and treat HIV. Dr. Bryson is a strong advocate for mothers and children with HIV. She is also an expert in general pediatrics, herpes infections, and other viral, bacterial, and opportunistic infections.

(131) 082 - 5086

8635 West 3rd Street 880W,Los Angeles,CA

About Dr. Nasseri Yosef Nasseri, MD, FACS, FASCRS, is a double board-certified surgeon specializing in general and colorectal surgery and a leader in minimally invasive and robotic surgery.  At Surgery Group of Los Angeles located at the Cedars Sinai Medical Towers and his office in West Hollywood, California, Dr. Nasseri provides concierge-style service, often available for same-day or next-day consultations with patients who need surgical solutions for a variety of lower digestive tract diseases, including Crohns disease, diverticulitis, and colon cancer. Dr. Nasseri is a leading expert in the latest cutting-edge technologies in minimally invasive laparoscopic and da Vinci® robotic surgery.  Dr. Nasseri has been hand-picked by Da Vinci Robotic company to train surgeons internationally and is the key national opinion leaders in all matters related to robotic surgery.  Dr. Nasseri is especially proficient in the latest cutting-edge technologies in minimally invasive laparoscopic and da Vinci® robotic surgery. In addition to his clinical work, Dr. Nasseri is actively involved in teaching and research. He is the author of numerous journal articles and book chapters. He holds several high positions in various national surgical committees, including the American Society of Colon and Rectal Surgeons, the American College of Surgeons, Society of Gastrointestinal and Endoscopic Surgeons, Southwestern Surgical Congress and the Consortium for Optimizing the Treatment of Rectal Anal Cancer. He has been elected by his peers to serve on the board of governors of the esteemed American College of Surgeons.  Dr. Nasseri has also been active in committees at Cedars Sinai Medical Center in Los Angeles. Dr. Nasseri earned a bachelors degree from the University of California – Los Angeles. After earning his medical degree at Albert Einstein College of Medicine in the Bronx, New York, Dr. Nasseri completed a seven-year residency in general surgery from Cedars-Sinai Medical Center, dedicating one year to research. For his residency in colorectal surgery, Dr. Nasseri finished his training at the renowned Cleveland Clinic Foundation in Weston, Florida. When not working with his patients, Dr. Nasseri is known for his work with charitable organizations, including medical missions to third-world countries and assisting disadvantaged communities in the area.

(142) 425 - 6054